UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005431
Receipt number R000006444
Scientific Title Multicenter Randomized Controlled Trial of Combination Antiemetic Therapy with Aprepitant/Fosaprepitant in Patients with Colorectal Cancer Receiving Oxaliplatin-based chemotherapy
Date of disclosure of the study information 2011/04/14
Last modified on 2019/05/15 16:11:40

No. Disposal Last modified on Item of update
1 Insert 2011/04/13 10:03:27
2 Update 2011/04/19 13:08:08 Recruitment status
3 Update 2012/10/12 17:02:18 Public title
Public title
Acronym
Acronym
4 Update 2012/10/12 17:06:48 Narrative objectives1
Narrative objectives1
5 Update 2012/10/12 17:20:41 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
6 Update 2013/10/18 11:10:33 TEL
Email
Last name of contact person
Last name of contact person
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2014/04/14 14:53:14 Recruitment status
Last follow-up date
8 Update 2015/01/09 10:42:37 UMIN ID1
9 Update 2015/08/12 17:58:48 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
10 Update 2018/05/14 18:57:52 Randomization unit
11 Update 2018/05/14 18:58:23 Name of primary person or sponsor
Organization
12 Update 2018/05/14 19:02:00 Other related information
Other related information
13 Update 2019/05/15 09:24:18 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
14 Update 2019/05/15 15:52:49 Recruitment status
Date of IRB
Anticipated trial start date
15 Update 2019/05/15 16:11:40 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures